WHO/Yoshi Shimizu
© Credits

Tuberculosis

    Overview

    Tuberculosis (TB) is the world’s top infectious killer.  According to the Global Tuberculosis Report 2024, in 2023, the Western Pacific saw an estimated 1.9 million TB cases and 95 000 deaths.

    TB is caused by bacteria (Mycobacterium tuberculosis) that most often affect the lungs. TB is spread from person to person through the air. When people with lung TB cough, sneeze or spit, they propel TB germs into the air. A person needs to inhale only a few of these germs to become infected. 

    About one-quarter of the world's population has latent TB infection, which means people have been infected by TB bacteria but are not (yet) ill with the disease and cannot transmit the disease. People infected with TB bacteria have a 5–10% lifetime risk of falling ill with TB. However, persons with compromised immune systems, such as people living with HIV, malnutrition or diabetes, or people who use tobacco, have a much higher risk of falling ill.  

    People with active TB can infect 10–15 other people through close contact over the course of a year. Without proper treatment, 45% of HIV-negative people with TB on average and nearly all HIV-positive people with TB will die. 

    The good news is that TB is curable and preventable. 

    Symptoms

    Common symptoms of TB disease include: 

    • Prolonged cough 
    • Chest pain 
    • Weakness or fatigue 
    • Weight loss 
    • Fever 
    • Night sweats 

    Often, these symptoms will be mild for many months, thus leading to delays in seeking care and increasing the risk of spreading the infection to others.  

    If a healthcare provider suspects a patient has TB disease, they will send the patient for testing. In the case of suspected lung TB disease, patients will be asked to give a sputum sample to test for TB bacteria. For non-lung TB disease, samples of affected body fluids and tissue can be tested. WHO recommends rapid molecular diagnostic tests as initial tests for people showing signs and symptoms of TB.

    With TB infection, a person gets infected with TB bacteria that lie inactive in the body. This infection can develop into TB disease if their immune system weakens. People with TB infection do not show any signs or symptoms of TB. To identify TB infection, healthcare providers will screen at-risk patients to rule out active TB, and they may use a skin or blood test to check for TB infection. 

    Treatment

    TB disease is curable. It can be treated with a standard 6-month course of 4 antibiotics. Common drugs include rifampicin and isoniazid. In some cases, the TB bacteria does not respond to the standard drugs. In this case, the patient has drug-resistant TB. Treatment for drug-resistant TB is longer and more complex.  

    The course of TB drugs is provided to the patient with  support by a health worker or trained volunteer. Without such support, treatment adherence can be difficult. If the treatment is not properly completed, the disease can become drug-resistant and can spread. 

    In the case of TB infection (where the patient is infected with TB bacteria but not ill), TB preventive treatment can be given to stop the onset of disease. This treatment uses the same drugs for a shorter time. Recent treatment options have shortened the treatment duration to only 1 or 3 months, as compared to the previous 6-month regimen.  

    Featured publications

    All →
    Western Pacific regional framework to end TB: 2021-2030: brief summary

    The Western Pacific Regional Framework to End TB (2021–2030) was developed at the request of and in consultation with the Member States in the World...

    Western Pacific regional framework to end TB: 2021-2030

    The regional TB Framework to End TB 2021-2030 was endorsed by the World Health Organization Regional Committee for the Western Pacific in 2021. The framework...

    Tuberculosis outbreaks in schools: experiences from the Western Pacific Region

    This document summarizes current evidence on TB outbreaks in schools and contextualizes the information within the Western Pacific Region. Case studies...

    A decade of progress towards better health - WHO in the Western Pacific Region 2009-2018

    This report presents WHO Western Pacific Region's progress over the period of 2009-2018 towards better health for the more than 1.9 billion people of this...

    Our work

    Videos

    All →

    Infographics

    All →